Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-07

Clinical Trial Update: Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial evaluating the safety, tolerability, and efficacy of Lecozotan SR in outpatients with Alzheimer's disease has completed phase 2 and phase 3 studi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lecozotan SR (lecozotan SR)

Snippet

Sponsor: Pfizer | Conditions: Alzheimer Disease | Phase 2, Phase 3 | Status: COMPLETED